Coronary outcomes with drug-coated balloon treatment
Part of Heart & circulation clinical trials.
This study tracks patients who receive a special balloon coated with medicine (paclitaxel) to open blocked heart arteries. It aims to understand how well this treatment works for various types of blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a new or recurrent narrowing in a heart artery or bypass graft that needs angioplasty (opening with a balloon).
- The narrowed area is in a vessel between 2.0 and 4.5 millimeters wide.
- You are able to take two blood-thinning medicines (dual antiplatelet therapy) after the procedure.
- You are not allergic to the medicine paclitaxel used on the balloon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a paclitaxel-coated balloon to treat narrowed heart arteries. It aims to see how well the balloon works in a wide range of patients with coronary artery disease who have symptoms or signs of reduced blood flow to the heart.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This trial tests a special balloon coated with medicine to treat plaque erosion, which is a common cause of heart attacks. The balloon delivers the drug directly to the narrowed artery, potentially reducing the need for a stent.
This study compares a drug-coated balloon (which releases medicine into the artery) with standard medicines alone for treating fatty plaques in the heart arteries. It is for people who have already had a heart attack and a successful opening of a blocked artery.
This trial tests whether a special balloon coated with medicine (drug-coated balloon) can safely open a completely blocked heart artery, instead of using a permanent stent. It may be an option for people who have chronic chest pain or shortness of breath due to a long-standing blockage.
This study records outcomes for people who get a drug-coated balloon used to treat a narrowed blood vessel after a first balloon treatment. It may help doctors understand how well this approach works in everyday care and for different patient needs.
Hear when a new Drug Coated Balloon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.